Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AMPH | US
0.22
0.47%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
04/10/2024
46.72
46.63
47.38
46.39
Amphastar Pharmaceuticals Inc. a bio-pharmaceutical company develops manufactures markets and sells generic and proprietary injectable inhalation and intranasal products in the United States China and France. The company operates through two segments Finished Pharmaceutical Products and Active Pharmaceutical Ingredient (API). It offers Primatene Mist an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; Lidocaine jelly an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation; and Vasopressin to increase blood pressure in adults with vasodilatory shock. Further the company distributes recombinant human insulin APIs and porcine insulin API. It serves hospitals care facilities alternate care sites clinics and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga California.
View LessStrong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
Price Below SMA10D
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
29.3%1 month
30.9%3 months
42.1%6 months
35.4%15.24
-
3.30
0.87
0.42
9.21
3.86
2.77
284.16M
2.29B
2.29B
-
30.27
49.00
25.20
25.57
11.71
12.83
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
4.26
Range1M
7.01
Range3M
14.05
Rel. volume
0.48
Price X volume
7.83M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Catalyst Pharmaceuticals Inc | CPRX | Drug Manufacturers-Specialty & Generic | 20 | 2.37B | 0.00% | 34.93 | 0.55% |
PAR Technology Corporation | PAR | Drug Manufacturers-Specialty & Generic | 52.65 | 1.91B | 6.00% | n/a | 65.19% |
Harrow Health Inc | HROW | Drug Manufacturers-Specialty & Generic | 50.37 | 1.79B | 9.79% | n/a | 331.16% |
Supernus Pharmaceuticals Inc | SUPN | Drug Manufacturers-Specialty & Generic | 32.02 | 1.76B | -0.44% | 341.67 | 4.18% |
Tilray Inc | TLRY | Drug Manufacturers-Specialty & Generic | 1.69 | 1.42B | 0.60% | n/a | 11.25% |
Collegium Pharmaceutical Inc | COLL | Drug Manufacturers-Specialty & Generic | 41.86 | 1.35B | 6.76% | 14.38 | 258.31% |
OPKO Health Inc | OPK | Drug Manufacturers-Specialty & Generic | 1.49 | 1.03B | -1.97% | n/a | 19.31% |
Evolus Inc | EOLS | Drug Manufacturers-Specialty & Generic | 16.34 | 1.03B | -4.67% | n/a | 656.27% |
PetIQ Inc | PETQ | Drug Manufacturers-Specialty & Generic | 30.87 | 923.02M | 0.13% | 83.11 | 178.54% |
Phibro Animal Health Corporation | PAHC | Drug Manufacturers-Specialty & Generic | 21.31 | 863.13M | -2.07% | 367.83 | 204.74% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
HNI Corporation | HNI | Building Products & Equipment | 53.27 | 2.51B | 0.72% | 21.28 | 76.47% |
Albany International Corp | AIN | Textile Manufacturing | 77.72 | 2.43B | -10.58% | 24.91 | 38.97% |
Fox Factory Holding Corp | FOXF | Recreational Vehicles | 40.42 | 1.68B | 0.17% | 42.66 | 64.69% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 57.84 | 1.66B | 0.98% | 21.48 | 56.33% |
Steelcase Inc | SCS | Building Products & Equipment | 12.97 | 1.47B | 0.78% | 12.50 | 65.47% |
REV Group Inc | REVG | Recreational Vehicles | 27.56 | 1.43B | 0.00% | 6.15 | 63.13% |
Janus International Group Inc. | JBI | Building Products & Equipment | 9.79 | 1.42B | 2.73% | 11.54 | 116.21% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.92 | 1.24B | 1.91% | n/a | -571.93% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 11.47 | 1.15B | 0.09% | n/a | 19.46% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 23.44 | 1.06B | -0.38% | n/a | 3644.76% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 9.21 | 17.21 | Cheaper |
Ent. to Revenue | 3.86 | 334.38 | Cheaper |
PE Ratio | 15.24 | 26.92 | Cheaper |
Price to Book | 3.30 | 12.15 | Cheaper |
Dividend Yield | - | 2.77 | - |
Std. Deviation (3M) | 42.12 | 68.34 | Lower Risk |
Debt to Equity | 0.87 | -1.00 | Expensive |
Debt to Assets | 0.42 | 0.48 | Par |
Market Cap | 2.29B | 5.31B | Emerging |